Type 2 Diabetes Market Value in the Asia-Pacific Is Expected to Increase $10.5 Billion in 2020; Finds New Report
The market for type 2 diabetes contains a wide range of drugs that are used to treat patients at different points in the treatment algorithm. The market landscape is dense, with a number of drugs competing for different market segments. Although the first-line therapy is usually metformin, a generic drug, it is often unable to bring the disease under control. Second-line therapy involves the use of other drugs in combination with metformin, and at this stage of the treatment algorithm...
View full press release